The Long Shot

Overview

The Long Shot groups three compounds that are each independently characterized in the literature on cellular metabolism, connective-tissue biology, and immune signalling. It ships as five separate vials, so the material corresponds to three distinct bodies of published work rather than to a single studied formulation.

NAD+ is a central redox coenzyme. Covarrubias et al. reviewed NAD+ metabolism and its roles in cellular processes during ageing, and Verdin surveyed its position in metabolism and neurodegeneration.[1][2] Rajman et al. reviewed the in vivo evidence for NAD-boosting molecules, and Imai and Guarente described the NAD+–sirtuin relationship.[3][4]

GHK-Cu is the copper-binding tripeptide first reported in Nature by Pickart et al. as a growth-modulating plasma tripeptide that may function by facilitating copper uptake into cells.[8] Maquart et al. reported stimulation of collagen synthesis in fibroblast cultures, and Pickart and Margolina reviewed its actions in light of gene-expression data.[9][11]

Thymosin Alpha-1 was isolated and sequenced by Goldstein et al. in 1977 as an immunologically active thymic polypeptide.[15] Romani et al. reported that it activates dendritic cells through toll-like receptor signalling, and Dominari et al. published a comprehensive review of the literature.[16][17]

No peer-reviewed study has evaluated these three compounds together as a kit. Every citation on this page describes a single component studied on its own, and the three act through unrelated molecular systems. Investigators should treat the kit as three separate research materials and consult the dedicated NAD+, GHK-Cu, and Thymosin Alpha-1 entries for complete mechanism, applications, and reference lists.

Reported Mechanisms — Component by Component

Each section below summarizes the published mechanism of a single component. No combined mechanism is described in the literature, and none is asserted here.

1. NAD+ (2,000 mg across 2 vials) — Redox Coenzyme and Enzyme Substrate

NAD+ operates both as an electron carrier in redox reactions and as a consumed substrate for enzyme families including sirtuins, PARPs, and CD38.[1][4] Tarragó et al. reported that a specific CD38 inhibitor reversed tissue NAD+ decline in an ageing model, and Zhang et al. reported that NAD+ repletion affected mitochondrial and stem-cell function in mice.[5][6] Grant et al. published a pilot study characterizing the plasma and urine NAD+ metabolome during intravenous infusion.[7]

2. GHK-Cu (100 mg, 1 vial) — Copper Coordination and Matrix Signalling

GHK binds Cu(II) with high affinity; Pickart et al. proposed that the complex facilitates copper uptake into cells.[8] Reported activities in fibroblast and skin models include stimulation of collagen synthesis, modulation of MMP-2 expression, and effects on MMP/TIMP balance and matrix proteins.[11][13] Pickart and colleagues also reported broad gene-expression modulation and antioxidant-gene regulation.[9][10][14]

3. Thymosin Alpha-1 (20 mg across 2 vials) — Toll-Like Receptor and Dendritic-Cell Signalling

Romani et al. reported that Thymosin Alpha-1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signalling, and in a later study reported activation of dendritic-cell tryptophan catabolism establishing a regulatory environment balancing inflammation and tolerance.[16][18] Serafino et al. reported activation of complement-receptor-mediated phagocytosis in human monocyte-derived macrophages.[20] Li et al. reviewed its biological activities and production, and Elizondo-Riojas et al. published an NMR structure.[19][22]

No published pharmacokinetic, pharmacodynamic, or interaction study has evaluated NAD+, GHK-Cu, and Thymosin Alpha-1 administered together. Any combined behaviour is unstudied.

Research Applications (Component-Level)

The published work behind each vial in this kit falls into the following areas. Every study listed used a single component, not the kit.

1. Cellular-ageing and metabolism models — NAD+ biology has been reviewed extensively in the context of ageing, metabolism, and neurodegeneration.[1][2][3]
2. Mitochondrial and stem-cell function — Zhang et al. examined NAD+ repletion in murine models.[6]
3. Extracellular-matrix and fibroblast models — GHK-Cu has been studied for collagen synthesis and MMP/TIMP expression in fibroblast culture.[11][13]
4. Wound-healing models — Canapp et al. examined a topical tripeptide-copper complex on healing of ischemic open wounds.[12]
5. Gene-expression profiling — GHK has been examined for broad transcriptional modulation.[9][10]
6. Innate and adaptive immune-signalling assays — Thymosin Alpha-1 has been studied in dendritic-cell, macrophage, and TLR-signalling systems.[16][18][20]
7. Structural and analytical characterization — an NMR structure of human Thymosin Alpha-1 supports assay and stability work.[22]

Important: no cited study used the combined kit. Researchers should not assume that single-agent findings carry over to co-administration.

Preclinical Research Summary (Component-Level)

No peer-reviewed study has evaluated this five-vial kit as a unit. The table below lists representative findings for each component individually. Full per-component data and complete reference lists are on the dedicated NAD+, GHK-Cu, and Thymosin Alpha-1 pages.